top of page

AGS Xenograft Model

Rincon Bio offers efficacy studies using the AGS Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Gastric
Derivation:
Epithelial line from gastric cancer of 54yo white female
Mutations:
CTNNB1, KRAS, PIK3CA, TP53
NCI60:
No
Weeks from stratification to termination (average):
6

AGS Growth Curve

(Representative of studies performed at Rincon Bio)

Contact Rincon Bio for a growth curve and more information on the AGS xenograft model.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page